Cannaflos Revenue and Competitors
Estimated Revenue & Valuation
- Cannaflos's estimated annual revenue is currently $2M per year.
- Cannaflos's estimated revenue per employee is $98,000
Employee Data
- Cannaflos has 20 Employees.
- Cannaflos grew their employee count by 11% last year.
Cannaflos's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & Partner | Strategic Alliances | Reveal Email/Phone |
2 | Scientific Affairs Manager | Reveal Email/Phone |
Cannaflos Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Cannaflos?
We will change this world for the better proving nature as medicine to heal people while spreading a new holistic paradigm to live in harmony with this planet. We provide medical cannabis to the expanding pool of German and European patients with constant availability of the highest quality products at an affordable price according to state of the art research with respect to a high degree of transparency and sustainability.
keywords:N/AN/A
Total Funding
20
Number of Employees
$2M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cannaflos News
2022-03-22 - Schnellere Regeneration mit CBD: Welche Vorteile ...
Im Anschluss an mein Studium habe ich bei Cannaflos gearbeitet, einer Firma, die verschreibungspflichtige Cannabis-Arzneimittel erforscht...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 20 | 5% | N/A |
#2 | $2.1M | 21 | -9% | N/A |
#3 | N/A | 23 | -8% | N/A |
#4 | N/A | 25 | 56% | N/A |
#5 | N/A | 25 | 39% | N/A |